Work

Novel Bispecific Degrader BHV-1310 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models including Nonhuman Primates (S18.009)

Year: 2025

Type: article

Source: Neurology

DOI: 10.1212/wnl.0000000000212548

Authors: Simone Nicholson, Elizabeth Dierks, Wes Kazmierski, Chuck Poole, Gene Dubowchik, David Pirman, David Spiegel, Anna Bunin, Neal Sharpe, Vlad Coric, Bruce Car

Institutions: Biohaven Pharmaceuticals (United States), Yale University

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409226388

FWCI:

Cites:

Cited by:

Related to: 10